Initial Treatment for Elevated Blood Pressure
For confirmed hypertension (BP ≥140/90 mmHg), start both lifestyle modifications AND pharmacological therapy simultaneously—do not delay medication while waiting to see if lifestyle changes work. 1
Immediate Pharmacological Treatment
First-Line Medication Choice
- Begin with a two-drug combination as initial therapy for most patients with BP ≥140/90 mmHg, preferably as a single-pill combination to improve adherence 1
- The preferred combinations are:
Exceptions to Two-Drug Initial Therapy
- Consider monotherapy (single agent) only for: 1
- Patients aged >80 years
- Frail patients
- Those with symptomatic orthostatic hypotension
- Elevated BP (120-139/70-89 mmHg) with specific high-risk conditions
For Black Patients
- Start with ARB + dihydropyridine calcium channel blocker OR calcium channel blocker + thiazide-like diuretic 1, 4
- ACE inhibitors are less effective as monotherapy in Black patients 1
Concurrent Lifestyle Modifications
While starting medication immediately, strongly emphasize these lifestyle changes (which may allow future medication reduction): 1, 5
- Sodium restriction to <2,300 mg/day 5, 6
- DASH eating pattern: 8-10 servings/day of fruits and vegetables, 2-3 servings/day of low-fat dairy 5, 7
- Weight loss if overweight (caloric restriction targeting healthy BMI) 5, 6
- Physical activity: At least 150 minutes/week of moderate-intensity aerobic exercise 5, 7
- Alcohol moderation: ≤2 drinks/day for men, ≤1 drink/day for women 5, 6
- Smoking cessation 5
- Increased potassium intake through dietary sources 5, 6
Treatment Escalation Algorithm
If BP Not Controlled on Two-Drug Combination
- Increase to three-drug combination: RAS blocker (ACE inhibitor or ARB) + dihydropyridine calcium channel blocker + thiazide/thiazide-like diuretic, preferably as single-pill combination 1
If BP Not Controlled on Three-Drug Combination
- Add spironolactone (mineralocorticoid receptor antagonist) 1
- If spironolactone not tolerated or contraindicated, consider: eplerenone, beta-blocker, alpha-blocker, or centrally acting agent 1
What NOT to Do
- Never combine two RAS blockers (ACE inhibitor + ARB together)—this is contraindicated 1
Monitoring Requirements
- Check serum creatinine and potassium 7-14 days after starting ACE inhibitor, ARB, or diuretic 5, 7, 4
- Reassess BP within 1-3 months until controlled, ideally achieving target within 3 months 1
- Target BP: 120-129/70-80 mmHg for most adults if well tolerated 1, 5
Special Populations
Patients with Specific Comorbidities
- Coronary artery disease: ACE inhibitor or ARB preferred 5
- Albuminuria (UACR ≥30 mg/g) or chronic kidney disease: ACE inhibitor or ARB mandatory to reduce progressive kidney disease 5, 4
- Heart failure: Add beta-blocker to regimen 5
Contraindications
- Women of childbearing potential: Provide reproductive counseling before prescribing ACE inhibitors or ARBs—these are teratogenic and absolutely contraindicated in pregnancy 5, 7
Common Pitfalls to Avoid
- Do not delay pharmacological treatment for 3-6 months to "try lifestyle changes first" in patients with BP ≥140/90 mmHg—the 2024 ESC guidelines explicitly recommend simultaneous initiation 1, 5
- The older approach of waiting 3-6 months applies only to elevated BP (120-139/70-89 mmHg) in low-risk patients without high-risk conditions 1, 7
- Do not start with monotherapy and uptitrate slowly—current evidence favors starting with two-drug combinations for faster BP control and better outcomes 1
- Do not underdose: Lisinopril 10 mg is the recommended starting dose, with usual maintenance of 20-40 mg daily 2; losartan starts at 50 mg with increase to 100 mg as needed 3